Search

Search Results

1. Prognostic PET [¹¹C]-acetate uptake is associated with hypoxia gene expression in patients with late-stage hepatocellular carcinoma – a bench to bed study

   Background

   Positron Emission Tomography (PET) with combined [ ¹⁸ F]-FDG and [ ¹¹ C]-acetate (dual-tracer) is used for the management of hepatocellular...

   Keith Wan Hang Chiu, Kel Vin Tan, ... Jason Wing Hon Wong in Cancer Imaging

   Article Open access 22 March 2024
   

2. A review of PET attenuation correction methods for PET-MR

   Despite being thirteen years since the installation of the first PET-MR system, the scanners constitute a very small proportion of the total hybrid...

   Georgios Krokos, Jane MacKewn, ... Paul Marsden in EJNMMI Physics

   Article Open access 11 September 2023
   

3. Recent Update on PET/CT Radiotracers for Imaging Cerebral Glioma

   Positron emission tomography/computed tomography (PET/CT) has dramatically altered the landscape of noninvasive glioma evaluation, offering...

   Dongwoo Kim, Suk-Hyun Lee, ... Mi** Yun in Nuclear Medicine and Molecular Imaging

   Article 21 February 2024
   

4. Use of ¹¹C-acetate PET imaging in the evaluation of advanced atherogenic lesions

   The use of ¹¹ C-acetate as a PET/CT tracer for atherosclerotic lesions preferentially labels anti-inflammatory/pro-resolution intra-plaque...

   Victoria Fernández-García, Lisardo Boscá in Journal of Nuclear Cardiology

   Article 04 March 2021
   

5. Uncovering atherosclerotic cardiovascular disease by PET imaging

   Assessing atherosclerosis severity is essential for precise patient stratification. Specifically, there is a need to identify patients with residual...

   Alexander Maier, Abraham J. P. Teunissen, ... Mandy M. T. van Leent in Nature Reviews Cardiology

   Article 04 April 2024
   

6. PET imaging of new target CDK19 in prostate cancer

   Purpose

   Prostate-specific membrane antigen (PSMA)-positron emission tomography (PET) is a superior method to predict patients’ risk of cancer...

   Dong Dai, Jiang Yu, ... Yu Zhao in European Journal of Nuclear Medicine and Molecular Imaging

   Article 06 June 2023
   

7. The Potential Role of PET in the Management of Peripheral Artery Disease

   Purpose of Review

   Current non-invasive tests for evaluating patients with peripheral artery disease (PAD) have significant limitations for early...

   Alaa Alashi, Billy C. Vermillion, Albert J. Sinusas in Current Cardiology Reports

   Article 14 June 2023
   

8. Granzyme B PET imaging inflammation and remodeling in myocardial infarction

   Purpose

   This study aimed to evaluate whether granzyme B (GzmB)-targeted positron emission tomography (PET) imaging agent ( ⁶⁸ Ga-grazytracer) can...

   Hongchuang Xu, Zhuxin Wei, ... Shihua Zhao in European Journal of Nuclear Medicine and Molecular Imaging

   Article 22 November 2023
   

9. Preclinical characterisation of gallium-68 labeled ferrichrome siderophore stereoisomers for PET imaging applications

   Background

   Siderophores are small iron-binding molecules produced by microorganisms to facilitate iron acquisition from the environment. Radiolabelled...

   Kristyna Krasulova, Barbora Neuzilova, ... Milos Petrik in EJNMMI Radiopharmacy and Chemistry

   Article Open access 04 March 2024
   

10. Prospective comparison of [¹⁸F]AlF-NOTA-octreotide PET/MRI to [⁶⁸Ga]Ga-DOTATATE PET/CT in neuroendocrine tumor patients

    Background

    Fluorine-18-labeled SSAs have the potential to become the next-generation tracer in SSTR-imaging in neuroendocrine tumor (NET) patients...

    Lennert Boeckxstaens, Elin Pauwels, ... Christophe M. Deroose in EJNMMI Research

    Article Open access 01 June 2023
    

11. 18F-Choline PET/CT or PET/MR and the evaluation of response to systemic therapy in prostate cancer: are we ready?

    Purpose

    During the last decade, [18F]F-choline positron emission tomography (PET) had a rising role in prostate cancer (PCa) imaging. However, despite...

    Luca Urso, Federica Lancia, ... Mirco Bartolomei in Clinical and Translational Imaging

    Article Open access 28 July 2022
    

12. Noradrenaline transporter PET reflects neurotoxin-induced noradrenaline level decrease in the rat hippocampus

    Background

    The neuropathological changes of early Alzheimer’s disease (AD) include neurodegenerative loss of noradrenaline neurons in the locus...

    Takayuki Sakai, Saori Hattori, ... Yasuyuki Kimura in EJNMMI Research

    Article Open access 15 September 2023
    

13. Peptide-based PET imaging agent of tumor TIGIT expression

    Background

    Accumulating studies have demonstrated that elevated TIGIT expression in tumor microenvironment correlates with better therapeutic response...

    Dinghu Weng, Rong Guo, ... **uman Zhou in EJNMMI Research

    Article Open access 02 May 2023
    

14. A comparative study of [⁶⁸Ga]Ga-FAPI-04 PET/MR and [¹⁸F]FDG PET/CT in the diagnostic accuracy and resectability prediction of ovarian cancer

    Purpose

    To provide a theory for guiding clinical treatment by comparing the clinical application value of [ ¹⁸ F]fluorodeoxyglucose ([ ¹⁸ F]FDG) PET/CT...

    Yun **, Lili Sun, ... Weiwei Feng in European Journal of Nuclear Medicine and Molecular Imaging

    Article 24 April 2023
    

15. The Complementary Role of PET to Pathology in Differentiating the Primary Origin of a Malignant Skin Nodule from Liver or Lung

    Metastasis from unknown primary is always a challenge because finding the true primary tumor significantly affects subsequent management. We present...

    Ivan Ho, Sirong Chen, ... Chi Lai Ho in Nuclear Medicine and Molecular Imaging

    Article 10 October 2022
    

16. Low TLR and PSMA-TV predict biochemical response to abiraterone acetate in metastatic prostate cancer patients develo** castration resistance after chemohormonal therapy at hormone-sensitive stage

    Objective

    To explore whether ⁶⁸ Ga-PSMA-11 PET/CT-derived parameters could predict biochemical response to abiraterone acetate (AA) treatment and...

    Zhi-Bin Ke, Jia-Yin Chen, ... Ning Xu in Journal of Cancer Research and Clinical Oncology

    Article 04 November 2022
    

17. Comparison of ⁶⁸Ga-FAPI-04 and ¹⁸F-FDG PET/CT in diagnosing ovarian cancer

    Purpose

    This study assesses the diagnostic performance of ⁶⁸ Ga-FAPI-04 PET/CT compared to ¹⁸ F-FDG PET/CT in primary, recurrent, and metastatic...

    Yunuan Liu, Jiangyang Pan, ... Huiqing Yuan in Abdominal Radiology

    Article 27 June 2024
    

18. Optimization of an Allysine-Targeted PET Probe for Quantifying Fibrogenesis in a Mouse Model of Pulmonary Fibrosis

    Purpose

    Idiopathic pulmonary fibrosis (IPF) is a destructive lung disease with a poor prognosis, an unpredictable clinical course, and inadequate...

    Sergey Shuvaev, Rachel S. Knipe, ... Peter Caravan in Molecular Imaging and Biology

    Article 23 August 2023
    

19. Clinical applications and prospects of PET imaging in patients with IDH-mutant gliomas

    PET imaging using radiolabeled amino acids in addition to MRI has become a valuable diagnostic tool in the clinical management of patients with brain...

    Michael M. Wollring, Jan-Michael Werner, ... Norbert Galldiks in Journal of Neuro-Oncology

    Article Open access 29 December 2022
    

20. Abiraterone acetate/enzalutamide/LHRH receptor agonists

    in Reactions Weekly

    Article 30 September 2023